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ABSTRAK
Tujuan: untuk menentukan peran laktat serum dan derajat beratnya ketoasidosis diabetikum (KAD) dalam 
memprediksi mortalitas lima hari pasien KAD. Metode: penelitian kohort prospektif dilakukan pada pasien KAD 
yang masuk perawatan di ruang gawat darurat RS Cipto Mangunkusumo, Jakarta, Indonesia pada periode 
tahun 2007-2008. Prediktor mortalitas 5 hari yang diteliti meliputi laktat serum dan derajat beratnya KAD 
(glukosa plasma, pH arteri, bikarbonat serum, osmolalitas, anion gap, dan perubahan kesadaran) pada awal 
perawatan. Cox’s proportional hazard regression model digunakan untuk menentukan prediktor independen 
terhadap mortalitas 5 hari pada pasien KAD. Hasil: dari enam puluh pasien yang diikutkan dalam penelitian, 
24 (40%) pasien di antaranya  meninggal dalam waktu 5 hari perawatan. Pada analisis multivariat, konsentrasi 
laktat ≥4 mmol/L (HR, 3,09; 95% IK, 1.36-7.05), dan tingkat kesadaran stupor/koma (HR, 3,38; 95% IK, 1,45-
7,87) diidentifikasi sebagai prediktor independen terhadap mortalitas 5-hari pasien KAD dewasa. Kesimpulan: 
konsentrasi laktat ≥4 mmol/L dan tingkat kesadaran stupor/koma dapat digunakan untuk memprediksi mortalitas 
5-hari pada pasien KAD.
Kata kunci: ketoasidosis diabetik, sepsis, konsentrasi laktat, tingkat kesadaran, mortalitas.
ABSTRACT 
Aim: to determine the role of serum lactate and diabetic ketoacidosis (DKA) severity as predictors for five-
days mortality in DKA patients. Methods: a prospective cohort study was conducted in DKA patients admitted to 
emergency department (ED) at Cipto Mangunkusumo Hospital, Jakarta, Indonesia, during 2007-2008 periods. 
Predictors for 5 days mortality in DKA patients in this study including serum lactate and DKA severity (plasma 
glucose, arterial blood pH, serum bicarbonate, osmolality, anion gap, and alteration in sensorium) at admission. 
Cox’s Proportional Hazard Regression Analysis was used to determine independent predictors for 5-days mortality 
among study population. Results: sixty patients with diabetic ketoacidosis were enrolled in the study; in which 24 
(40%) patients were died within 5 days after admission. In the multivariate analysis, the lactate level ≥4 mmol/L 
(HR, 3.09; 95% CI, 1.36-7.05) and altered in sensorium stuporous/comatose (HR, 3.38; 95% CI, 1.45-7.87) were 
identified as independent predictors for 5-days mortality in DKA adult patients. Conclusion: lactate level ≥4 mmol/L 
and altered in sensorium stuporous/comatose can be used to predict 5-days mortality in adult patients with DKA.
Key words: diabetic ketoacidosis, sepsis, lactate level, alteration in sensorium mortality.
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INTRODUCTION
Diabetic ketoacidosis (DKA) is the most 
serious and life-threatening acute complication of 
diabetes and is characterized by hyperglycemia, 
ketosis, and acidosis.1,2 The current diagnostic 
criteria and classifications of the severity of DKA 
are based on plasma glucose, arterial pH, serum 
bicarbonate, serum osmolarity, anion gap, and 
mental state alterations.2,3 The majority of DKA 
cases are precipitated by infections,2 which have 
a high incidence rate, especially in developing 
countries.4 Despite significant improvements 
in monitoring and therapy, the mortality rate 
remains high, especially in DKA patients with 
sepsis.5
In our tertiary hospitals, the mortality 
associated with DKA is likely to be high because, 
characteristically, these patients often have 
low incomes, comorbidities, delays in seeking 
medical care, and a high rate of infections. The 
initial fluid therapy protocol for treating DKA, 
which is based on evidence-based management, 
recommends that resuscitation should consist of 
isotonic saline (0.9% NaCl) infused at a rate of 
15-20 mL/kg/h during the first hour.3,6 In sepsis, 
where patients have hypoperfusion or septic 
shock, fluid resuscitation should follow the 
early goal-directed therapy (EGDT) protocol.7 
This approach seeks to achieve the following 
targets as a resuscitation end point: central 
venous pressure (CVP) of 8 to 12 mmHg, 
mean arterial pressure (MAP) ≥65 mmHg, 
and superior vena cava oxygenation (Scvo2) 
saturation ≥70%; these tests should be completed 
within the first 6 hours.8 Early recognition and 
management of sepsis is key to improving patient 
outcomes.8,9 The Surviving Sepsis Campaign 
(SSC) recommends that in septic patients, lactate 
measurement within 3 hours should be used as a 
marker of tissue hypoperfusion to help identify 
patients at high risk for death and those who will 
benefit from the EGDT approach. Hypoperfusion 
and perfusion abnormalities may include an acute 
alteration in mental status.8
Until now, there is no prospective study 
describing the prognostic value of serum lactate 
and DKA severity on emergency department 
(ED) admission as predictors of mortality in 
DKA patients, shortly after admission to the 
emergency department. Therefore, we conducted 
this study to determine the roles of mortality 
predictors in adult DKA patients using serum 
lactate and severity of DKA on ED admission.
METHODS
This was a prospective cohort study 
conducted at the Emergency Department of Cipto 
Mangunkusumo Hospital, a tertiary hospital in 
Jakarta, Indonesia. Diabetic ketoacidosis (DKA) 
patients, aged 16 years and older, who admitted 
from January 2007 through December 2008 and 
agreed to participate were included in the study, 
with exclusion criteria was pregnant women. 
Diabetic ketoacidosis was diagnosed when the 
blood glucose at admission was >250 mg/dL with 
ketonaemia and blood acidemia (pH <7.3 or a 
serum bicarbonate concentration of <15 mEq/L).2 
The University Ethics Committee approved the 
study, and informed consent was obtained from 
all patients or their representatives.
Identification of Predictors and Outcome
The classification severity of DKA was 
based on the following: plasma glucose, arterial 
blood pH, serum bicarbonate, osmolality, anion 
gap and alterations in sensorium.2 Alterations in 
sensorium were stratified into 2 groups: alert/
drowsy, and stupor/coma. Serum osmolality 
was derived from the following formula: 2x 
[measured Na+ (mEq/L)] + glucose (mg/dL) / 18. 
The anion gap was calculated using the following 
formula: [(Na+)–(Cl- + HCO3- (mEq/L)].2
Arterial lactate samples were collected 
with heparinized syringes, and the subsequent 
measurements were performed using a Hitachi 
917 automated analyzer (Roche Diagnostics, 
Mannheim, Germany). The lactate results were 
stratified into 2 groups based on the cutoff values 
previously utilized by other authors10; these 
groups were as follows: <4.0 mmol/L and ≥4.0 
mmol/L.8,10
The patient characteristics, comorbidities, 
triggers of DKA, vital signs, clinical findings, 
blood collection results, and lactate measurements 
were recorded for each individual upon arrival 
at the emergency department for enrollment. 
The criteria for sepsis was defined according 
to the 2001 SCCM/ESICM/ACCP/ATS/SIS 
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International Sepsis Definitions Conference.11 
We defined the mortality outcome as 
any death occurring ≤5 days from the initial 
lactate measurement.10,12,13 All patients were 
treated according to a DKA standardized Cipto 
Mangunkusumo hospital protocol.
Statistical Analysis
The sample size of the study was estimated 
based on an assumption 81.25% incidence 
of mortality for high lactate concentrations.14 
Assuming the relative risk is 1.75, with α = 
0.05 and β = 0.20, minimal subjects required 
in the study was 58 patients. Univariate 
analysis comparing serum lactate levels and 
the classification of DKA severity on five-days 
mortality was performed to identify variables 
that potentially had a significant association 
with mortality. All variables with p-value <0.25 
in univariate analysis  were entered into a Cox’s 
Proportional Hazard Regression Model using a 
backward selection algorithm to calculate the 
adjusted hazard ratios of mortality. Kaplan-
Meier Curve for each significant predictors were 
presented. All statistical analyses were performed 
using the STATA statistical software version 9 
(Stata Corp., College Station, TX, USA).
RESULTS 
Patient Characteristics
A total of 60 patients with DKA were 
enrolled in the study with mean age of 50.97 
(SD 2.05) years 36 (60%) of them were women 
and 35 (58%) patients were diagnosed DKA 
with sepsis. The main sites of infection in the 
septic group were the respiratory tract (51%), 
followed by soft tissue (34%), gastrointestinal 
tract (6%), abdomen (3%), and others (6%). The 
precipitating factors of DKA in the non-septic 
patients were insulin omission (32%), stroke 
(20%), new-onset diabetes (8%), trauma (8%), 
tumor (8%), and gastrointestinal bleeding (4%). 
Precipitating factors could not be identified in 
20% of patients.
Out of the 60 patients, 24 (40%) died within 
5 days. Mortality in the septic patients (57%) 
was significantly higher than in the non-septic 
patients (16%). Serum lactate in the septic 
patients (median: 2.89 mmol/L, range: 0.85 to 
13.49 mmol/L) was significantly higher than in 
the non-septic patients (median: 1.67 mmol/L, 
range: 0.68 to 8.26 mmol/L). The patients’ 
characteristics are presented in Table 1. 
Table 1. Diabetic ketoacidosis patients: comparison of survivors and non-survivors
Variables Survivors (n=36) Non-survivors (n=24)
Sex (n, male/female) 17/19 7/17
Mean age (year)a 48.11 (SD 16.24) 54.92 (SD 15.97)
Blood pressure (SBP/DBP)a 118 (SD 19.93) / 67.22 (SD 23.37) 112.17 (SD29.30) / 63.75 (SD 28.41)
Temperature (°C)a 37.38 (SD 1.00) 37.04 (SD 1.79)
Heart rate (bpm)a 111.4 (SD 16.97) 111.4 (SD 14.35)
Respiration rate (bpm)a 29.00 (SD 8.36) 31.18 (SD 5.51)
Leukocyte count (/mm3)a 17,600 (SD 7715) 21,000 (SD 7500)
Serum lactate (mmol/L)b 1.70 (0.68-8.26) 4.2 (0.85-13.49)*
Glucose (mg/dL)a 442.33 (SD 140.47) 498.88 (SD 158.67)
Arterial pHa 7.31 (SD 0.13) 7.24 (SD 0.17)
Serum bicarbonate (mEq/L)a 12.11 (SD 5.12) 10.85 (SD 4.79)
Osmolality (mOsm/kg)a 295.07 (SD 23.04) 297.42 (SD 19.45)
Anion gapa 21.57 (SD 7.76) 24.03 (SD 5.53)
Sepsis (n,%) 15 (43%) 20 (57%)**
a data presented as the mean ± standard deviation
b data presented as median, range
* p<0.05 by Mann-Whitney U test, **p<0.05 by Chi-Square Tests
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Twelve of the 17 patients (71%) with high 
lactate levels (≥4 mmol/L) had normal blood 
pressure. The neurological symptoms alertness/
drowsiness and stupor/coma occurred in 40 
(67%) and 20 (33%) patients, respectively. Eight 
drowsy patients (62%) and 13 out of 20 (65%) 
stupor/coma patients had accompanying sepsis. 
The univariate analysis to predict mortality 
using serum lactate and the classification of 
DKA severity are presented in Table 2. The 
variables that had a significant effect based on 
univariate analysis were submitted to Cox’s 
Proportional Hazard Regression Model. The 
following variables were found to be independent 
predictors of mortality: serum lactate ≥4 mmol/L 
and alterations in sensorium stuporous/comatose. 
organ dysfunctions.15 Tissue hypoperfusion is an 
important factor in the development of multiple 
organ failure. Therefore, the early recognition of 
sepsis-induced tissue hypoperfusion is crucial in 
implementing aggressive resuscitation to prevent 
organ damage.16 Markers of tissue hypoperfusion 
include lactate levels.8
Our prospective study identified prognostic 
factors to predict 5-day mortality. Two variables 
were independently associated with mortality, 
specifically, serum lactate and alterations in 
sensorium. As reported by others, lactate levels 
were significantly higher in septic patients. 
Azoulay et al.17 studied a retrospective analysis 
of 113 DKA patients treated in a medical ICU. 
They found that the lactate levels ranged from 
1.9 to 3.3 mmol/L (median: 2.7) in patients with 
infection and from 1.3 to 1.8 mmol/L (median: 
1.4) in patients without infection. Other authors 
have reported that the lactate levels were 2.61 
SD 0.56 mmol/L in DKA septic patients and 
1.32 SD 0.24 mmol/L in non-septic patients.5 
In the present study, we observed that DKA 




Serum lactate  
≥4 mmol/L
3.76 (1.69-8.38)
Glucose (mg/dL) 1.00 0.99-1.00
Arterial pH 0.21 0.02-2.23
Serum bicarbonate 
(mEq/L) 0.97 0.90-1.06
Osmolality (mOsm/kg) 1.00 0.98-1.02
Anion gap 1.03 0.97-1.08
Alterations in sensorium 
Stuporous/Comatose 4.24 (1.86-9.64)





Serum lactate  
≥4 mmol/L
3.09 1.36-7.05
Alterations in sensorium 
Stuporous/Comatose 3.38 1.45-7.87
DISCUSSION
As reported by others, sepsis is one of the 
most common precipitating factors of DKA.3,5 
Mortality in sepsis may occur in the early phase 
(in the first 5 days) or the late phase (after 5 
days).10,12,13 The mechanisms of mortality in the 
early phase are generally due to cardiovascular 
collapse, metabolic derangements, and multiple 
FIgure 1. Kaplan-Meier survival estimates
Suhendro Suwarto                                                                                                     Acta Med Indones-Indones J Intern Med
22
patients with high lactate levels (≥4.0 mmol/L) 
had significantly higher mortality than patients 
with low lactate levels (<2.0 mmol/L). To our 
knowledge, no other prospective studies have 
reported high lactate levels in DKA and its 
association with high mortality. A potential 
reason that may explain our result was the 
patients’ delays in seeking medical care, which 
resulted in more severe disease and, therefore, 
higher mortality rates. Rivers et al.9 demonstrated 
a significant mortality benefit for patients with 
severe sepsis and septic shock when early 
diagnosis and rapid intervention was provided 
within the first 6 hours. Furthermore, our data 
demonstrated that blood pressure levels were not 
different between survivors and non-survivors. 
In addition, we found patients who had a lactate 
level ≥4.0 mmol/L in the presence of normal 
blood pressure. These results confirm that 
normotensive patients with high lactate levels 
or cryptic shock have a higher risk of death than 
patients with normal serum lactate.18 Puskarich et 
al.19 reported that the risk of death in patients with 
high lactate levels was similar between those 
with cryptic and overt shock. These results are 
consistent with other studies that have reported 
that a lactate level ≥4.0 mmol/L increases the 
probability of acute mortality.10,12
Altered mental status was another predictor 
of mortality in our study. The cause of altered 
sensorium in DKA remains unclear; it may 
be due to various possibilities, including 
reduced cerebral blood flow, reduced glucose 
utilization, hyperosmolality and high blood 
glucose concentrations, acidosis, or a direct effect 
of ketone bodies or other factors.20 According 
to the recent International Sepsis Definitions 
Conference, the diagnostic criteria for sepsis 
now includes altered mental status as a marker 
of global hypoperfusion.8 Tissue hypoperfusion 
is an important factor in the development of 
multiple organ failure, which is a major cause 
of death in septic patients.15,16 In our study, 65% 
of the stupor/coma patients at admission also 
had an accompanying diagnosis of sepsis, and 
these characteristics were significantly related to 
mortality. These results are consistent with other 
studies that have reported that DKA patients 
who present with disorientation, confusion, or 
stupor at admission are more likely to also have 
infections.17 In septic patients, encephalopathy 
was associated with mortality when graded by 
the Glasgow Coma Score. A score of 15 had a 
16% mortality rate, 13 to 14 had a 20% mortality 
rate, 9 to 12 had a 50% mortality rate, and 3 to 8 
had a 63% mortality rate (p < 0.05) (21). Chung 
et al.22 conducted a retrospective study of 164 
patients with hyperglycemic crises to determine 
the clinical characteristics and predictors of 
mortality. They found that infection (74%) was 
the most common trigger of hyperglycemic 
crises. In a multivariate analysis, altered mental 
status on admission and age were associated 
with mortality.22
In the population that we studied, there were 
35 patients (58%) with sepsis. Mortality was 
significantly higher in these patients than in the 
non-septic patients. This indicates that a patient 
with serum lactate ≥4 mmol/L and alteration 
in sensorium stuporous/comatose is likely due 
to sepsis-induced tissue hypoperfusion, and 
in such cases, patients should be immediately 
resuscitated.
This mortality prediction may help clinicians 
to identify the possibility of sepsis as a trigger 
of DKA patients. Based on DKA guidelines, 
the initial fluid therapy in DKA should consist 
of isotonic saline (0.9% NaCl) at a rate of 
15-20 mL/kg/h or 1-1.5 L within one hour. 
Therefore, rehydration should be guided by the 
hemodynamic status, state of hydration, serum 
electrolyte levels, and urinary output.3,6 However, 
according to the Surviving Sepsis Campaign, the 
goals of initial resuscitation of sepsis-induced 
hypoperfusion should include CVP 8 to 12 
mmHg, MAP ≥65 mmHg, and Scvo2 ≥70% 
(EGDT), and these goals must be achieved within 
the first 6 hours.8 This strategy has demonstrated 
a significant reduction of in-hospital mortality 
compared with the standard therapy (30.5% 
vs. 46.5%).7 Recent studies have shown that 
the outcome of sepsis may be improved with 
early recognition of hypoperfusion and optimal 
resuscitation.23 By using this mortality prediction 
may provide an initial risk-stratification tool 
to identify patients at high risk of death, and 
may help clinicians can consider to determine 
the appropriate resuscitation protocol to be 
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used for a particular patient. This study has 
several limitations that need to be considered. 
First, we did not consider the effects of patient 
comorbidities, which may have influenced the 
outcomes. Second, definite causes of the patients’ 
altered mental status were not identified. Third, 
because our study was conducted at a single 
institution, a tertiary referral hospital in Jakarta, 
Indonesia, the results may not be representative 
of all DKA patients.
CONCLUSION
Lactate level and altered in sensorium 
(stuporous/comatose) on admission to the 
emergency department can be used to predict 
acute mortality in DKA adult patients.
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